[Anti-retrovirals].
Roca
B
B
Unidad de Enfermedades infecciosas, Hosptial General de Castellón.
Simón
E
E
D019380:Anti-HIV Agents / Q000009:adverse effects / Q000494:pharmacology*; D016049:Didanosine / Q000009:adverse effects / Q000494:pharmacology; D018894:Reverse Transcriptase Inhibitors / Q000494:pharmacology*; D018119:Stavudine / Q000009:adverse effects / Q000494:pharmacology; D016047:Zalcitabine / Q000009:adverse effects / Q000494:pharmacology; D015215:Zidovudine / Q000009:adverse effects / Q000494:pharmacology
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D015215:Zidovudine; D016047:Zalcitabine; D018119:Stavudine; D016049:Didanosine